Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Trial Type:  Treatment
Treatment/Intervention:  RNA interference therapy
Results 1-2 of 2 for your search:
Start Over
APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis
Phase: Phase III
Type: Treatment
Age: 18 to 85
Trial IDs: ALN-TTR02-004, NCI-2014-01434, 2013-002987-17, NCT01960348
Start Over